These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 18192671

  • 1. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.
    Ata B, Yakin K, Balaban B, Urman B.
    Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C.
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection.
    Razieh DF, Maryam AR, Nasim T.
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):245-8. PubMed ID: 19797013
    [Abstract] [Full Text] [Related]

  • 4. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.
    Ghanem ME, Sadek EE, Elboghdady LA, Helal AS, Gamal A, Eldiasty A, Bakre NI, Houssen M.
    Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001
    [Abstract] [Full Text] [Related]

  • 5. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H.
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J, Cholquevilque JL, Cela V, Martínez-Salazar J, Requena A, Garcia-Velasco JA.
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916).
    Safdarian L, Mohammadi FS, Alleyassin A, Aghahosseini M, Meysamie A, Rahimi E.
    Hum Reprod; 2007 Sep; 22(9):2449-54. PubMed ID: 17635844
    [Abstract] [Full Text] [Related]

  • 10. GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial.
    Bellver J, Labarta E, Bosch E, Melo MA, Vidal C, Remohí J, Pellicer A.
    Fertil Steril; 2010 Aug; 94(3):1065-71. PubMed ID: 19501354
    [Abstract] [Full Text] [Related]

  • 11. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C, Donnez J, Loumaye E.
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [Abstract] [Full Text] [Related]

  • 12. Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection.
    Isikoglu M, Ozgur K, Oehninger S.
    J Reprod Med; 2007 Jul; 52(7):639-44. PubMed ID: 17847764
    [Abstract] [Full Text] [Related]

  • 13. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial.
    Urman B, Ata B, Yakin K, Alatas C, Aksoy S, Mercan R, Balaban B.
    Hum Reprod; 2009 Jul; 24(7):1640-7. PubMed ID: 19357135
    [Abstract] [Full Text] [Related]

  • 14. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
    Drakakis P, Loutradis D, Vomvolaki E, Stefanidis K, Kiapekou E, Anagnostou E, Anastasiadou K, Milingos S, Antsaklis A.
    Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
    [Abstract] [Full Text] [Related]

  • 15. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A.
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [Abstract] [Full Text] [Related]

  • 16. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles.
    Lukaszuk K, Liss J, Lukaszuk M, Maj B.
    Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571
    [Abstract] [Full Text] [Related]

  • 17. GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study.
    Aboulghar MA, Marie H, Amin YM, Aboulghar MM, Nasr A, Serour GI, Mansour RT.
    Reprod Biomed Online; 2015 Jan; 30(1):52-6. PubMed ID: 25456166
    [Abstract] [Full Text] [Related]

  • 18. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E, Devroey P.
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [Abstract] [Full Text] [Related]

  • 19. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C, Lindenberg S, Nordic Crinone Study Group.
    Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
    [Abstract] [Full Text] [Related]

  • 20. Ovarian hyperresponse to luteal phase GnRH-agonist administration.
    Depenbusch M, Diedrich K, Griesinger G.
    Arch Gynecol Obstet; 2010 Jun; 281(6):1071-2. PubMed ID: 19960348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.